Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
We combine clinical and experimental data through machine learning techniques to explore human disease biology and promote the development of precision medicine. Our innovative Contingent AI™ technology comprehends the intricate relationships present in the data, yielding advanced insights. To combat data bias, we refine our machine learning models based on decisions made during the pre-processing and feature engineering phases. We utilize zebrafish, cellular, and various phenotypic animal models to test and confirm in silico predictions through in vivo experiments, along with genetic modifications conducted both in vitro and in vivo to enhance translation. By employing active learning and computer vision on validated models that focus on cardiac, central nervous system, and rare disorders, we swiftly integrate new data into our machine learning frameworks, allowing for continuous improvement and adaptation in our methodologies. This iterative process not only enhances the accuracy of our predictions but also enables us to stay at the forefront of research in precision medicine.
Description
Pearl's innovative platform, powered by artificial intelligence, empowers healthcare teams to cut unnecessary expenses, enhance patient outcomes, and thrive in value-based care by pinpointing priority patients and encouraging timely interventions while seamlessly fitting within existing workflows without causing disruption. This technology merges predictive analytics with effective action; it emphasizes significant outreach and automates subsequent steps, evaluates provider readiness and cohort risk to align participants with suitable payment models, and links intelligence to action to foster measurable advancements in clinical, financial, and operational performance. Moreover, it integrates flawlessly into provider systems, enabling teams to deliver high-quality care on a large scale. The platform's advanced data-science and actuarial capabilities maximize savings, improve benchmarks, and support various models like ACO REACH, MSSP, and Medicare Advantage, all while equipping physicians with user-friendly tools that streamline care delivery, alleviate them from mundane tasks, and enhance management of patient panels. Ultimately, Pearl's solution stands out in the healthcare landscape by prioritizing efficiency and effectiveness in care delivery, ensuring that both providers and patients benefit from its comprehensive features.
API Access
Has API
No
API Access
Has API
No
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Types of Training
Training Docs
No
Webinars
No
Live Training (Online)
No
In Person
No
Types of Training
Training Docs
Yes
Webinars
No
Live Training (Online)
Yes
In Person
Yes
Vendor Details
Company Name
BioSymetrics
Country
United States
Website
www.biosymetrics.com/platform
Vendor Details
Company Name
Pearl Health
Founded
2020
Country
United States
Website
www.pearlhealth.com/technology